Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 10.21 is 16% above its 5-year average of 8.79, near the low end of its 5-year range (0.04–42.80).
As of the fiscal period ended Friday, July 31, 2026. 0.20% below its 12-month average of 10.23.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-07-31): 10.21.
QUICK RATIO (ACID-TEST)
10.21
QUICK RATIO (ACID-TEST) AVG TTM
10.23
QUICK RATIO (ACID-TEST) AVG 3Y
13.33
QUICK RATIO (ACID-TEST) AVG 5Y
8.79
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-0.20%
CURRENT VS 3Y AVG
-23.36%
CURRENT VS 5Y AVG
+16.23%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+204.88%
vs the sector median at left
enGene Holdings Inc.
Market Cap
$120.58M
Quick Ratio (Acid-Test)
10.21
TTM Avg
10.23
3Y Avg
13.33
5Y Avg
8.79
Market Cap
$120.41M
Quick Ratio (Acid-Test)
14.06
TTM Avg
14.20
3Y Avg
21.81
5Y Avg
28.51
Market Cap
$118.83M
Quick Ratio (Acid-Test)
13.31
TTM Avg
17.30
3Y Avg
10.78
5Y Avg
9.73
Market Cap
$122.43M
Quick Ratio (Acid-Test)
0.65
TTM Avg
1.74
3Y Avg
2.55
5Y Avg
2.19
Market Cap
$118.59M
Quick Ratio (Acid-Test)
4.52
TTM Avg
5.53
3Y Avg
5.99
5Y Avg
10.25
Market Cap
$122.66M
Quick Ratio (Acid-Test)
6.61
TTM Avg
6.63
3Y Avg
5.56
5Y Avg
6.65
Market Cap
$117.76M
Quick Ratio (Acid-Test)
9.23
TTM Avg
4.04
3Y Avg
4.74
5Y Avg
7.63
Market Cap
$124.18M
Quick Ratio (Acid-Test)
0.18
TTM Avg
2.21
3Y Avg
2.68
5Y Avg
2.62
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| enGene Holdings Inc. (ENGN) | $120.58M | 10.21 | 10.23 | 13.33 | 8.79 |
| Seer, Inc. (SEER)vs › | $120.41M | 14.06 | 14.20 | 21.81 | 28.51 |
| Cibus, Inc. (CBUS)vs › | $119.84M | 1.62 | 0.78 | 1.43 | 2.39 |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | 13.31 | 17.30 | 10.78 | 9.73 |
| BGM Group Ltd. (BGM)vs › | $122.43M | 0.65 | 1.74 | 2.55 | 2.19 |
| Tenaya Therapeutics, Inc. (TNYA)vs › | $118.59M | 4.52 | 5.53 | 5.99 | 10.25 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 6.61 | 6.63 | 5.56 | 6.65 |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | 9.23 | 4.04 | 4.74 | 7.63 |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | 0.18 | 2.21 | 2.68 | 2.62 |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 11.47 | 9.04 | 10.96 | 10.73 |
Quick Ratio
10.21
Excludes inventory
Current Ratio
10.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | 10.21 |
| 2026-04-30 | 12.57 |
| 2026-01-31 | 11.75 |
| 2025-10-31 | 6.30 |
| 2025-07-31 | 10.34 |
| 2025-04-30 | 12.66 |
| 2025-01-31 | 17.16 |
| 2024-10-31 | 16.87 |
| 2024-07-31 | 19.52 |
| 2024-04-30 | 42.80 |
| 2024-01-31 | 12.97 |
| 2023-10-31 | 16.24 |
| 2023-07-31 | 0.04 |
| 2023-04-30 | 0.22 |
| 2022-12-31 | 0.57 |
| 2022-10-31 | 1.16 |
| 2022-07-31 | 2.05 |
| 2022-04-30 | 2.73 |
| 2021-12-31 | 4.79 |
